Oxidative stress can attack precursor nucleotides, resulting in nucleic acid damage in cells. It remains unclear how 8-oxo-dGTP and 8-oxoGTP, oxidized forms of dGTP and GTP, respectively, could affect DNA or RNA oxidation levels and tumor development. To address this, we intravenously administered 8-oxo-dGTP and 8-oxoGTP to wild-type and MTH1 -knockout mice. 8-oxoGTP administration increased frequency of tumor incidence, which is more prominent in MTH1 -knockout mice. However, 8-oxo-dGTP treatment rather reduced tumor development regardless of the mouse genotype. The tumor suppressive effects of 8-oxo-dGTP were further confirmed using xenograft and C57/6J-ApcMin/Nju mouse models. Mechanistically, 8-oxo-dGTP increased the 8-oxo-dG contents in DNA and DNA strand breakage, induced cell cycle arrest in S phase and apoptosis mediated by AIF, eventually leading to reduced tumor incidence. These results suggest distinct roles of 8-oxo-dGTP and 8-oxoGTP in tumor development. [Display omitted] • 8-oxo-dGTP does not increase but rather prevents tumors in MTH1 -KO and WT mice. • 8-oxo-dGTP inhibits the growth of xenograft tumors and intestinal polypoid tumors. • 8-oxo-dGTP increases 8-oxo-dG in DNA strands and causes DNA damage. • 8-oxo-dGTP causes the S-phase arrest and induces apoptosis mediated by AIF. [ABSTRACT FROM AUTHOR]